Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth in issues and stay up to date on the latest trends. We encourage you to subscribe to our monthly publication Policy and Medicine Compliance Update.
The August issue our focus again is on litigation and enforcement across a wide spectrum of topics. We begin with two cases involving the 340B drug discount program. First, we examine how a hospital system focused on the rebate potential of the program and allegedly engaged in kickbacks and false claims involving the acquisition of an oncology clinic.
Next, we review the recent Supreme Court decision in the American Hospital Association (AHA) case challenging HHS 340B reimbursement reductions. Not unexpectedly, the Court handed a win to the AHA.
Leaving the U.S., we focus on the Italian Sunshine Act. Italy has joined other EU countries requiring disclosure of transfers of value to HCPs and HCOs, but with a uniquely Italian spin on implementation.
Sticking with the international arena, we examine the OECD’s latest foreign bribery recommendations. The recommendations not only focus on the recipients of bribes, but they also contain important considerations for compliance programs.
Rounding out this issue, we look at the myths surrounding using of integrated risk management software and the latest case involving FCA whistleblowers before the Supreme Court.
Articles
FEATURE
DOJ Intervenes in Methodist...
"I will note that in 2024, troops were -- that was Joe Biden by the way, Joe Biden -- were deployed to polling locations in 15 states," Hegseth said April 29, 2026 before the House of Representati...